Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2000
12/28/2000WO2000078763A2 Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
12/28/2000WO2000078740A1 Solid-supported initiators and functional polymers for use in organic synthesis and combinatorial chemistry
12/28/2000WO2000058317B1 (thio) phosphoryl triamides for regulating the enzymatic urea hydrolysis
12/28/2000DE19928306A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
12/28/2000DE19911680A1 New extracts and compounds from Ganoderma pfeifferi , useful e.g. as antibacterial and antiviral agents, preservatives, cosmetic, pharmaceutical and food additives and in fish farming, are protease inhibitors
12/27/2000EP1063234A2 Hydrophobic taxane derivates
12/27/2000EP1062358A1 Novel method for preparing fexofenadine
12/27/2000EP1062262A1 Method for producing a liquid formulation of tetraphenylphosphonium phenolate
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062221A1 Process for making glyphosate by oxidizing n-substituted glyphosates
12/27/2000EP1062219A1 Integrated process for preparation of diene complexes
12/27/2000EP0886638A4 Improved process for the synthesis of oligomeric compounds
12/27/2000CN1278262A Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic
12/27/2000CN1278169A (N,N')-bis (sulfonyl) hydrazines useful as antineoplastic agents
12/27/2000CN1277968A Method for prepn. and purification of phosphine oxide
12/27/2000CN1059906C Water-soluble phosphine-derivatives
12/26/2000US6166260 Enantioselectively reducing carbonyl or carbonyl-bearing chemical entities with chiral hydride complex reducing agents; resolving the reduction product through the formation of a complex of the reduction product and the ligand
12/26/2000US6166239 Useful during oligonucleotide synthesis to protect nucleobase amines as well as tethered amines used for attaching functional moieties to oligonucleotides.
12/26/2000US6166234 Tripodal cyclopentadiene derivatives and their use
12/26/2000US6166218 Benzotriazole UV absorbers having enhanced durability
12/26/2000US6166089 Prodrugs with enhanced penetration into cells
12/26/2000US6166006 Having antagonistic activity on mcp-1 (monocyte chemoattractant protein-1) receptor; antiinflammatory agents
12/26/2000US6165997 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165943 Herbicides
12/26/2000US6165501 Radiation-protective phospholipid and method
12/26/2000CA2127067C Phosphonic acid derivatives, their preparation process and pharmaceutical compositions containing them
12/21/2000WO2000077014A1 Aryl phosphates
12/21/2000WO2000077013A1 Disulfone reagents and methods of preparing and using same
12/21/2000WO2000077012A1 Bisphenol-a bis(diphenyl phosphate)-based flame retardant
12/21/2000WO2000051987A3 Inhibitors of advanced, post-amadori glycosylation reactions
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000027860A8 Polynucleotide crosslinking agents
12/21/2000DE19927787A1 Verfahren zur Herstellung von Alkylphosphonsäuren A process for the production of alkylphosphonic acids
12/20/2000EP1061084A1 Process for the preparation of alkylphosphonic acids
12/20/2000EP1060793A1 Stereospecific isomerisation of allylamines with the aid of immobilised phosphorated chiral ligands
12/20/2000EP1060264A1 Dideoxy dye terminators
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060174A1 Nitric oxide releasing chelating agents and their therapeutic use
12/20/2000EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents
12/20/2000EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
12/20/2000EP1060160A2 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
12/20/2000EP1060017A1 Deeply reduced oxidation catalyst and its use for catalyzing liquid phase oxidation reactions
12/20/2000EP0833832B1 A process for the preparation of a dop-containing mixture
12/20/2000CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/20/2000CN1277201A Method of extracting high-purity acephate from acephate raw oil
12/20/2000CN1059674C Hypolipidemic benzothiazepines
12/20/2000CN1059673C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
12/20/2000CN1059671C 3-aryl-akenyl-1,2,4-oxadiazole derivatives
12/19/2000US6162931 Fluorinated xanthene derivatives
12/19/2000US6162929 Process for the manufacture of bisphosphine oxide and bisphosphonate compounds
12/19/2000US6162927 (2s,3r,4s)-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)-1-(n,n-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid, or salt or ester thereof, in pure form; adminstering to treat hypertension, other diseases
12/19/2000US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
12/19/2000US6162810 Inadone and tetralone compounds for inhibiting cell proliferation
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162799 Silicon substituted naphthoquinones
12/19/2000US6162756 Tin catalysts, a process for their production, their use and cross-linkable mixtures containing them
12/19/2000CA2001225C Antimicrobial lactam-quinolones
12/14/2000WO2000075150A1 Ip3 receptor ligands
12/14/2000WO2000075149A1 Process for preparing low-acid-value phosphoric esters
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000WO2000075120A1 Diaminothiazoles and their use for inhibiting protein kinases
12/14/2000WO2000074674A1 Novel porphyrin derivatives for photodynamic therapy
12/14/2000WO2000047568A3 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
12/14/2000WO2000045770A3 Compressed lecithin preparations
12/14/2000DE19923615C1 Verfahren zur Herstellung von Alkylphosphonigsäureestern Process for the preparation of alkylphosphonous acid esters
12/14/2000DE19918284C1 Preparation of aqueous solution of sulfonated arylphosphine, useful in catalysts for hydroformylation of olefins, involves reacting arylphosphine with oleum, diluting and blowing inert gas through the solution
12/14/2000CA2373336A1 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000CA2371158A1 Diaminothiazoles and their use for inhibiting protein kinases
12/13/2000EP1059310A2 Polymerization of alpha-olefins with transition metal catalyst based on bidentate ligands containing pyridine or quinoline moiety
12/13/2000EP1059298A1 Process for purifying L-ascorbyl 2-monophosphate
12/13/2000EP1058686A1 2'-fluoronucleosides
12/13/2000EP1058685A1 Compounds having an ionic structure used as constituent of an olefin polymerisation catalyst
12/13/2000EP1058672A1 Process and apparatus for preparation of phosphorus oxyacids from elemental phosphorus
12/13/2000CN1276793A Methylenebisphosphonic acid derivs.
12/13/2000CN1276792A Weakly coordinating anions contg. polyfluoroalkoxide ligands
12/13/2000CN1276377A Method for purifying L-ascorbic acid 2-monophosphate
12/13/2000CN1276376A Vitamin D precursor of phosphine oxide
12/12/2000US6160180 Tertiary phosphanes containing alkylene glycol groups
12/12/2000US6160167 Mercaptans and disulfides
12/12/2000US6160166 Phosphonated agents and their antiangiogenic and antitumorigenic use
12/12/2000US6160165 Preparing a stirred slurry of pamidronate in water, adding a solution of sodium hydroxide to give a clear solution at ph of about 6.5, filtering, freezing and lyophilizing the solution to form amorphous anhydrous disodium pamidronate
12/12/2000US6160164 Aminophosphorous acids and aminophosphonic acids corrosion inhibitor protective coatings for metal surfaces
12/12/2000US6160153 Phosphorothioate monoester functional crosslinking, conjugating and reducing agents
12/12/2000US6160115 Prepared by reaction of (4-(4-fluorophenyl)-6-isopropyl-2-(n-methyl-n-methylsulfonylam ino)pyrimidin-5-yl)methanol with chlorodiphenylphosphine; chemical intermediates for hmg-coa reductase inhibitors
12/12/2000US6160109 Preparation of phosphorothioate and boranophosphate oligomers
12/12/2000US6160009 Excitatory amino acid receptor modulators
12/12/2000US6160008 Pharmaceutical compositions comprising S-alkylisothiouronium derivatives
12/12/2000US6159957 Antitumor agents
12/12/2000CA2029073C Scale control in aqueous systems
12/07/2000CA2310903A1 Process for purifying l-ascorbyl 2-monophosphate
12/06/2000EP1056755A1 Fungicides
12/06/2000EP1056754A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
12/06/2000EP1056450A1 Farnesyl-protein transferase inhibitors
12/06/2000CN1275572A Polyether modified quaternary microcosmic salt, its preparation process and use
12/06/2000CN1059211C Chirality epoxy phosphine ligand compound and synthesis and application thereof
12/05/2000US6156935 Chiral phosphorus-based ligands
12/05/2000US6156934 Diphosphines
12/05/2000US6156873 Bismuth dendrimers, processes for their preparation, and their use as x-ray contrast agents
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 554